An interventional study of hysteroscopic endo-myometrial biopsy and ultrasound in Adenomyosis, sponsored by Woman's Health University Hospital, Egypt. Completed at 1 site in Egypt. Open to female participants aged 38 Years to 52 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-07-28.
Sponsored by Woman's Health University Hospital, Egypt · Not applicable, Interventional, and Diagnostic
The purpose of this study is to develop and evaluate a hysteroscopic endo-myometrial biopsy for diagnosing adenomyosis.
135 studies on the registry are indexed under Adenomyosis; 50 are open to participants now.
This study's planned enrollment of 200 is above the median of 100 across 73 interventional studies indexed under Adenomyosis.
Browse Adenomyosis studies →Woman's Health University Hospital, Egypt is the lead sponsor of 46 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
females attending the gynecology outpatient clinic complaining of chronic pelvic congestion will get enrolled in the study. Two dimensional ultrasonography will be performed to asses the presence or absence of adenomyosis or any associated lesions. All the patients were then be subjected to office hysteroscopy and endo-myometrial biopsies will be taken. Histopathological examination of the samples will then be done. From these recruited patients, some will be indicated to perform hysterectomy. The final diagnosis will then be based on the histopathological examination of the specimen retrieved from hysterectomy. The accuracy of the ultrasound and the hysteroscopic endo-myometrial biopsy will then be compared and assessed.
Procedure: hysteroscopic endo-myometrial biopsy · Device: ultrasound
two dimensional trans-vaginal ultrasonography
Number of participants with diagnosis of adenomyosis cases
Time frame: 6 months
This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Woman's Health University Hospital, Egypt